These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 3770164)

  • 1. [Clinical pharmacology of membrane-destabilizing processes in nephropathies in children].
    Krylov VI; Petrushina AD; Zhmurov VA
    Farmakol Toksikol; 1986; 49(5):114-6. PubMed ID: 3770164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of antioxidants and miscleron on destabilization of cell membranes during nephritis in children].
    Zhmurov VA; Krylov VI; Petrushina AD
    Vopr Med Khim; 1987; 33(1):40-3. PubMed ID: 3577056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indomethacin the treatment of glomerular nephropathies].
    Genova R; Tamborino G
    Minerva Pediatr; 1973 May; 25(19):826-32. PubMed ID: 4581628
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant treatment in glomerular nephropathies in children].
    Schneer JH; Chipail A; Constantinescu V; Brumăr OM
    Pediatria (Bucur); 1973; 22(1):69-73. PubMed ID: 4733565
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indomethacin in nephropathies in children. Apropos of 21 cases].
    Pierron H; Manassero J; Vaillaud JC; Paglia R; Orsini A
    Pediatrie; 1971 Mar; 26(2):167-73. PubMed ID: 5554434
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood phospholipids in patients with different clinical manifestations of chronic glomerulonephritis and preserved kidney function].
    Riabov SI; Kulikova AI; Mitrofanova OV
    Ter Arkh; 1995; 67(2):51-4. PubMed ID: 7725261
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression in the treatment of glomerulonephritis.
    Soothill JF; Barratt TM
    Adv Nephrol Necker Hosp; 1971; 1():75-81. PubMed ID: 5006260
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical application of the polyunsaturated n-3 fatty acids usage in pediatric practice.
    Kutafina EK; Netrebenko OK; Gorelova JU; Levachev MM; Garankina TI
    Z Ernahrungswiss; 1998; 37 Suppl 1():125-7. PubMed ID: 9558744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of chloxyl and praziquantel treatment on the lipid phase of the erythrocyte membrane and on the antioxidant system in opisthorchiasis patients].
    Nalobin VA; Zhmurov VA; Nalobin SA
    Med Parazitol (Mosk); 1994; (1):23-6. PubMed ID: 8015517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Criteria of pharmacologic effectiveness of antioxidant and membrane-stabilizing drugs in various disorders of cerebral circulation].
    Rakhimdzhanov AR; Shamsiev ES; Krylov VI
    Farmakol Toksikol; 1989; 52(4):70-3. PubMed ID: 2806534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N
    Vutr Boles; 1984; 23(5):59-67. PubMed ID: 6523843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of hemopoietic system during immunosuppressive treatment in kidney diseases in children].
    Halikowski B; Garwicz S; Kucharska K; Saewicz-Pach K; Wyszkowski J
    Pediatr Pol; 1969 Jun; 44(6):657-66. PubMed ID: 5802240
    [No Abstract]   [Full Text] [Related]  

  • 13. Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients.
    Hino K; Murakami Y; Nagai A; Kitase A; Hara Y; Furutani T; Ren F; Yamaguchi Y; Yutoku K; Yamashita S; Okuda M; Okita M; Okita K
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1269-75. PubMed ID: 16872308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of treating glomerulonephritis patients with a hematuria component].
    Pyrih LA; Dudar IO; Kolesnyk MO
    Lik Sprava; 1992 Mar; (3):3-6. PubMed ID: 1413681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment results in various morphological patterns of glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1984; 56(9):97-101. PubMed ID: 6515557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodepressive therapy in nephropathies].
    Zosin C; Mănescu N; Iacob G; Schwarzkopf A; Sabo I; Gluhovschi G
    Stud Cercet Med Interna; 1969; 10(2):137-46. PubMed ID: 5344003
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
    Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
    Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of comparative effectiveness of various methods of complex therapy of acute glomerulonephritis in children].
    Gnatiuk AI; Saulenko TA
    Pediatriia; 1992; (4-6):79. PubMed ID: 1408585
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction to the symposium on the anti-inflammatory and immunosuppressive therapy of some glomerular nephropathies].
    Fiaschi E
    Minerva Nefrol; 1969; 16(2):93-4. PubMed ID: 4320649
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood ceruloplasmin levels in some childhood nephropathies].
    Masi M; Vecchi V; Vivarelli F; Paolucci P
    Minerva Pediatr; 1975 Jun; 27(21):1182-6. PubMed ID: 1143207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.